The Peripheral Nervous System and the Physiology of Nociception

Exam Tip: Remember the "crossing" rule. The Spinothalamic tract crosses almost immediately in the spinal cord (contralateral projection), whereas the DCML stays ipsilateral until it reaches the medulla.

The Physiology of Nociception

Nociception is the neural process of perceiving noxious stimuli. It is not a single event but a multi-stage physiological process:

1. Transduction: Nociceptors (sensory neurons with free nerve endings) convert mechanical, thermal, or chemical stimuli into electrical action potentials.
2. Conduction: The electrical signal travels along peripheral nerve fibers. There are two main types of fibers involved:
   • A$\delta$ fibers: Myelinated and fast-conducting; they transmit "first pain," which is sharp and well-localized.
   • C fibers: Nonmyelinated and slow-conducting; they transmit "second pain," which is dull, aching, and diffused.
3. Transmission: The signal moves from the peripheral nerve to the spinal cord, where it synapses with second-order neurons in the dorsal horn.
4. Perception: The signal reaches the thalamus and is then projected to the somatosensory cortex (for localization) and the limbic system (for the emotional/affective response).
5. Modulation: The brain sends signals back down to the spinal cord to inhibit or facilitate the incoming pain signals.

Sensitization: When Pain Becomes Pathological

Under normal circumstances, pain is acute and protective. However, the nervous system can undergo changes that make it hypersensitive.

Peripheral Sensitization

This occurs at the site of tissue injury. When tissue is damaged, local mediators like prostaglandins (PGE2, PGI2), bradykinin, and substance P are released. These chemicals lower the activation threshold of nociceptors, meaning a stimulus that was once barely painful now triggers a strong response. This is often seen in inflammation, such as a burn or a toothache.

Central Sensitization

If noxious input is continuous, the spinal cord itself can become hypersensitive—a process called "spinal facilitation" or central sensitization. This involves changes in the dorsal horn, often mediated by neurotransmitters like glutamate (acting on NMDA and AMPA receptors) and neuropeptides like substance P and CGRP.

Central sensitization can lead to two distinct clinical phenomena:

• Hyperalgesia: An increased response to a stimulus that is normally painful.
• Allodynia: Pain caused by a stimulus that is normally innocuous (e.g., a light touch feeling like a burn).

Descending Modulation: The Body's Internal Pharmacy

The body does not passively receive pain; it actively attempts to dampen it through descending inhibitory pathways. These pathways originate in higher brain centers, such as the periaqueductal gray (PAG), and travel down to the dorsal horn of the spinal cord.

These descending neurons release inhibitory neurotransmitters and neuromodulators to block pain transmission at the synapse. Key players include:

• Enkephalins (endogenous opioids)
• GABA
• Serotonin (5-HT)
• Norepinephrine (Epinephrine)

By acting on both pre-synaptic and post-synaptic neurons, these pathways can reduce the amount of neurotransmitter (like glutamate or substance P) released into the synapse, effectively "turning down the volume" of the pain signal before it ever reaches the brain.

Summary Table: Key Neurotransmitters in Pain